/manager/Index ${session.getAttribute("locale")} 5 Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer /manager/Repository/uon:18606 Sat 24 Mar 2018 08:01:03 AEDT ]]> Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: Predictive value of centrally reviewed expression of estrogen and progesterone receptors - International Breast Cancer Study Group /manager/Repository/uon:5450 Sat 24 Mar 2018 07:48:10 AEDT ]]> Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial /manager/Repository/uon:4800 Sat 24 Mar 2018 07:20:39 AEDT ]]>